#Canada #Greenway #Cannabis #Kingsville #Financials

Overview

Greenway Greenhouse Cannabis Corporation, a notable player in the Canadian cannabis sector, has recently disclosed its financial statements for the first quarter ending June 30, 2025. The company, listed under CSE: GWAY and OTCQB: GWAYF, is based in Kingsville, Ontario, and specializes in cultivating high-quality greenhouse cannabis.

Financial Highlights

The financial report showcases impressive year-over-year improvements. One of the most significant highlights is the average net sales price per gram, which surged to $1.71 from $1.11 in the previous quarter, marking a remarkable 54% increase. Meanwhile, the cash cost per gram of finished goods witnessed a decline to $0.70, down from $0.92 in the earlier quarter, resulting in the largest difference between sales price and cash cost in the company’s history.

In terms of revenue, Greenway reported net cannabis revenue of $1,621,062, compared to $2,394,159 in the same quarter last year. Despite the dip in total revenue, the company achieved a gross profit of $841,227, substantially higher than $342,922 from the prior period.

Greenway's gross margin saw a dramatic improvement, rising to 50%, in contrast to only 14% achieved in the previous year. Even the adjusted EBITDA reached $78,723, compared to $316,431 last quarter, attributing the enhanced gross margin as a pivotal element of this financial performance.

Notably, the net loss narrowed significantly to $166,453, a positive shift of $375,025 or 69% decrease compared to last year's quarter.

Additionally, the company has successfully maintained a finished goods inventory of 1,274,617 grams valued at $1,174,581, ensuring they can meet future purchase orders. With a robust cash balance of $2,192,005, Greenway continues to maintain a sound working capital position of $4,203,627.

International Expansion Strategy

Greenway is proactively pursuing international opportunities, as highlighted by their recent supply agreement with 4C LABS, a leading UK-based medical cannabis firm. This strategic venture, initiated on July 31, 2025, aims to supply high-quality dried flower products to fulfill the growing demand in the UK market. As Greenway embarks on this international growth strategy, enhancing their finished goods inventory allows the company to manage the prolonged sales cycles typical in international transactions.

Jamie D'Alimonte, CEO of Greenway, stated, “This quarter demonstrates the resiliency of our model and the discipline of our team. Despite lower volumes, we achieved significantly higher pricing, improved gross margins, and a substantial reduction in net loss.” He added that their focus remains on aligning production with profitable sales channels, including wholesale, branded products, and international markets.

Carl Mastronardi, President of Greenway, emphasized, “We have fortified our balance sheet while reducing cash costs per gram. With a finished goods inventory exceeding 1.2 million grams, Greenway is poised to fulfill upcoming orders both domestically and internationally.”

The company highlights that their recent partnership with 4C LABS is expected to help stabilize their sales price while boosting quarterly volumes in the coming periods.

Conclusion

In conclusion, Greenway Greenhouse Cannabis Corporation's first quarter results reflect a promising trajectory with substantial improvements in key financial metrics. The combination of increased sales prices, improved margins, and strategic international agreements positions the company favorably for future growth. Investors and stakeholders keenly await further developments as Greenway continues to advance within the cannabis market.